Davis Polk advised the counterparties in connection with uncollared accelerated share repurchase transactions they entered into with Monsanto Company (“Monsanto”) pursuant to which Monsanto is repurchasing an aggregate of $3 billion of its common stock. Under the terms of the transactions, Monsanto will receive an aggregate initial delivery of approximately 28.4 million shares of its common stock based on current market prices. The final number of shares to be repurchased under each transaction will be based on a discount to the volume-weighted average stock price during the term of such transaction. The final settlement of the transactions is expected to occur in the next six months.   

Monsanto is a leading global provider of agricultural products for farmers.    

The Davis Polk equity derivatives team included partner Ray Ibrahim and associates Katharine O’Banion, Robert Stewart and Won Lee. All members of the Davis Polk team are based in the New York office.    

Copy link to share post